Aging is associated with reduced inflammatory disease activity independent of disease duration in relapsing multiple sclerosis trial populations.
Coerver EM, Kaçar S, Ciccarelli O, Sormani MP, Barkhof F, Arnold DL, Schoonheim MM, Van Kempen ZL, Mostert J, Koch MW, Killestein J, Eshaghi A, Uitdehaag BM, Strijbis EM.
Coerver EM, et al. Among authors: koch mw.
Mult Scler. 2024 Sep;30(10):1296-1308. doi: 10.1177/13524585241272938. Epub 2024 Sep 8.
Mult Scler. 2024.
PMID: 39245991
Free PMC article.